Growth Metrics

Greater Cannabis Company, Inc. (GCAND) Accumulated Expenses (2017 - 2022)

Greater Cannabis Company (GCAND) has 6 years of Accumulated Expenses data on record, last reported at $233000.0 in Q1 2022.

  • For Q1 2022, Accumulated Expenses rose 28524.08% year-over-year to $233000.0; the TTM value through Mar 2022 reached $233000.0, up 28524.08%, while the annual FY2021 figure was $18199.0, 8.01% up from the prior year.
  • Accumulated Expenses reached $233000.0 in Q1 2022 per GCAND's latest filing, up from $18199.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $233000.0 in Q1 2022 and bottomed at $814.0 in Q1 2021.
  • Average Accumulated Expenses over 5 years is $31462.7, with a median of $13143.0 recorded in 2018.
  • Peak YoY movement for Accumulated Expenses: plummeted 93.1% in 2021, then surged 28524.08% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $85000.0 in 2018, then tumbled by 75.74% to $20619.0 in 2019, then dropped by 18.28% to $16849.0 in 2020, then grew by 8.01% to $18199.0 in 2021, then skyrocketed by 1180.29% to $233000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $233000.0 in Q1 2022, $18199.0 in Q4 2021, and $12308.0 in Q3 2021.